Mani Mohindru
CIK 1664708 · Chief Executive Officer · last filed 2026-04-02
Mani Mohindru is a Chief Executive Officer who has filed 26 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for CRDF, was dated Apr 2, 2026. Across all open-market trades the lifetime net is −$2.1M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
26
-$2.05M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Chief Executive Officer | — | $1.54 | — | $0 | 7 | 2026-04-02 |
| CTMX | Director | — | $3.01 | — | $0 | 6 | 2025-06-13 |
| Tvardi Therapeutics, Inc. (CARA) Delisted | CFO & Chief Strategy Officer | 17,441 | $15.96 | $278.4K | -$2.05M | 10 | 2019-12-04 |
| CRIS | Chief Strategy Officer | — | $0.42 | — | $0 | 3 | 2017-02-16 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-02 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2026-02-18 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2025-06-30 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2022-03-10 | CRDF | Grant (A) | — | $0 | EDGAR |